Vanguard Portfolio Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$92.3M Sell
2,596,138
-9,637
-0.4% -$380K ﹤0.01% 1514
2026
Q2
$121M Buy
2,605,775
+328,969
+14% +$11.8M 0.01% 1436
2026
Q1
$55.8M Buy
+2,276,806
New +$53.9M ﹤0.01% 1639

Other funds holding ASTH

Vanguard Portfolio Management's ASTH Position: Q3 2026 in Review

Vanguard Portfolio Management reduced its Astrana Health (ASTH) stake by 0.37% in Q3 2026, selling an estimated $380K and leaving 2,596,138 shares worth $92.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1514.

Vanguard Portfolio Management first reported a position in ASTH in Q1 2026 and has held it in 3 quarters since. The position peaked at $121M in Q2 2026. 218 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.

  • Vanguard Portfolio Management held 2,596,138 shares of Astrana Health worth $92.3M as of Q3 2026.
  • Vanguard Portfolio Management sold 9,637 Astrana Health shares in Q3 2026, an estimated $380K.
  • Astrana Health made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1514 holding.
  • Vanguard Portfolio Management first reported a position in Astrana Health in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Portfolio Management's Astrana Health position peaked at $121M in Q2 2026.
  • 218 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.